Nbr rhanisiauuacslinizs website savisleuthy oe datastiinmnlwann 29 ow Sovemnranliion Vaniionts Tusensiimminsimeunisiouransalnsandioya Wo uacsiafitriuendniniasay DIN yori fe maenitamuine uawvinratonn seFauzeyndwusiamos lwvaiiavos “mmlaeiiu quawlummfnvandimuna’ tusewiwiuh 22-23 unnwu 2547 1 pnisinduman’ swimnduneseuntins domueviualunsia jot DIN tuiay Af oruditabieandin ae ahopnssstiworin naiznmMaMnsingsuMA dulundudoue: dosunrsiousiesauletumasaudn infoshunawtaifiondymuime io aanfin DIN Tunralivinas Foyat erie oduiiiadivotunigaunniacsnrssayngaans thes 2547 dundyitdutmumnrainmstunianl aandimniuacszayniunisiaumuasutina msiauo unaanNFs1ns uu website wos DIN fuse yainnrseioT ‘Tunoubtiinanmotivseqithuiioyamsdniuen tut 2516 Vaio mow sun 992 how ummrafisams dm 93 uaa, sondn saw 223 Tisnana 7 inna vindunumandinvimualidanfiensaunalivansnaumraniue aedonmunimaratins tu wennienssunvwahmndseunn Navuanaideny naisindumant amninuiduaovaruntuns Wh Aivinndaionmrinfidu used) 2546 Huu 2 yu fio 1. mhuindsmunalsomennants (an. cussAiind thilvA) 2. mbotndtsmumalssweinagasord (acy. qui qaimsAa) Sadmmifinoninandumume vo 2 Tanne a Winwiaw folumVasnnaouhmauacauamearatmnraiiuedaa Kos sosounnilunrariaiio 13 a lamas shutvvinufipamalowmast, aaudainumiedu umasavisimsti website v9 DIN anusfianyebiazaannmin pousnsaanys: anuiifinsia = jpharmacy.psu.ac.th : http:/iwww.Askrx.net putanrasbouraTonionpas narindammad x0. : Aduvinl : coniuthahmsndumaeduedou 9 2566 ue HusfisuneTaquaraan 4. Wannosfirafue truant ewiipadqnummuncithalssewlsionauurrsRMuuREN TaN AANA pnrinFayqnaqsim Sarr aorsimnrsaSqausran omens wascumatoed sflonaueunssion aii 3. uinromsiemaiuindtaernsurtonsTup dunno Wir nwa mains eer 4. iannnumwnasianimndinrabiiomrnlurraiann: Funan miiininwn Wiioyanay dum-aindin Rows ey ann numsrsqmonteimnitogamndiendwantsearay 5. vnphqstavioucrnal ot cnet en, ) ttn /anwy a got/eder! Information about the Producte We Regulate hitp://wmw.fdagov/ederdrugidetautu tin eves in rm| Characteristics asfimniiage (Biooquivalene, BE) snsuniSeuanitas wnftuwy dudoyentioAtMunstumeinur iets iesonqonreaeu mewn domaanandindn infinrdarhmuelaunnsnraiomnaae (FDA) doi thireidufioniivsry Aaksnglususunrnlssyivas Canadian So- clety for Pharmaceutical Sciences Symposium Avil 41. Palyiyk-Colwell (Alberta Blue Gross, Edmonton, Alberta) shisuniiofafusasnnenssunasaidonsuwrmpsrteinnursnent abodumntiodemonumeniiun lauorviuioya o& dutty assay Wlosvinnvfinn BE yrluormainaMAguA NE Zo “insaunguisusstnnilunds mares gory Win uareuiies wae inanilaninlisnsmsiinn BE Witudiummbifinranivtion doiy shiuniinrudutolstnaniscwwiaetAveonniwuk — wes Joyaluc-uhoimousines-yuang mass naniaalandasana 16 « 20 pu seerwriniuiaummoniresnnsdailngilaviels — dau itivindinanidoussnurdidh Setoslirshemaitoypesbserrts + sanainfioniihuuniay adhsletionathansnsduwndiinnaiioan std nfuuuuviniy ovdwinquaneariioshilunanwndiia visevin Somsonuilgnorstinrimuuannenutrdhanns 2. snmafinenesuniinewi 7 nioviniue oiltiazem MR ‘wilantia Taw F. Jamali (University of Alberta, Edmonton, Alberta) munmslidoye BE parameters shi AUC was Cmax \flusntira tdullsiearzauunermuansnaaes input-time profile 1a% MR dos: age torms 1H idssmin Cmax uanstannigedstusnanennia dy Aviellsdhiglumdimsinanseuen Wlmamunwnaa Vinton 8E sowkinAnnt MA ean partial AUG udu absorption phase Mow eneiunvlambiownienaheyianinn Teen ditazem MR defines wuiflviy circadian variation wilder infarction aasihuhahai daucedsuinlrenunuava etumngagnostinnandhiighumseauquarniilatatuaboath acta anncitiiawrndsty ume course soa isderauhdiqiionsinn Wut cardiovascular diseases, asthma, some allergies une Tuffae ar- thritis flown morning stiffness UNANANIAAgAANG, lence of Drug Products with ae we yw” 3. G Amidon (University of Michigan, Ann Asbour. Michi- gan) dusihch wit FA TirhSinnraesos 8E Ineiivarie uardammasasnngedu wine AUC was Cmax tu uiefbign foo Winsrinsefimtuionthmadnien maga’y manszvuus: mvirinn useisnhisuess ina Biopharmaceutios CI tion System (BCS) Bofmualaw FDA FeueUMaashL 4 catego: fies svaquaniat high/iow solublity wae/ ns high/low permeebil- ity ethelewilumainne in vivo-in vitro correlations ween fica ‘iovmaday in vitro dissolution Tunyatiure ia vive BE tu ant thai dandinhahanlieinivsw siavini controlled release sdovornvinr permeability uae metabolism oeivavin site de- pendant 4. P. du Soulch (UnWersity of Montreal, Montroal, Quebec) shuns MA_sansanumudanmsgagedhmondawalisinns sanqviitiu aiuq3! site of absorption wioan rate of input into the body thi malian erythromycin. ditiazem viieh AUC 399 MA snominses 1m wimiemagedsinga MA inaduilumauiuearnis HMnaniraos IR Soasesaninusrrniia tst pass metabolism use 1 metronidazole warsnnralamilioonmoyguia MR metus ermadauildt wopnozontes uaa ¥dnrinragndugeniguuy IR wonvimiugersas MA demaraniiunsaaumurmaidy Inge indie ttn furosemide, nifedipine Une calcium antagonists prezosin, 19 propronoiol unegay MA saranannniaiiosnys saw Wd ASA. nifedipine. verapamil, levodope, diazepam. carbamazepine, alprazolam daiutaiuiaasdvilunsinn BE sewhagar IR war MR Aasiinn pharmacological respons wis pharmacokinetic studies rananadws J Pharm Pharmaceut Sei (www.valberte.ce/-eapa) 1 (2):74-88, 1008 :/vrunw.alberta ca/-csps/JPPS12/ Foa. jum efiamis > fl arieintunnen x. Jrulyinilandussaongaryaun aici 91961 Tauvinin Ledere mosmnagousiny méuoanmoadt an vies Sunraunsy fi 22-ethslenedimino)--t-butarot ds Bu (6) LalaunoSvinstorilos TanslnAlatausio’ uacitdama Chomt- | Aastract (CA) fi 1-butanol22"-ethanedlimino}-bis. (S (RR 800 Lal eer, 1950 lAfin mirzy Cahn togold-Prelog (seu A/S) ‘tilunaduniiars ts Chemical Abstract MAsnyaauAgsinunos ()-Saowynoathi “s(hsny)" uasidwdouthuiansutelyyha Fo ‘WiMian wéumiTu. absolute configuration aestnBuswyroaly. Siu 9) Gufoseiinibienningiaiy BP (1980) uae EP 1987) 7 HanTlossatisros («)-Busxyrnainiin RA aszinksahiy USP aay 1920 awilnavatroxoy (+)-dusnyroRadudiniiuty wk ure iid R (RAY dau Clark's reference fitanslassw ya 9 (+)-Jussygnos iu A.A fan tustusit Kiyne's atlas Thuans (+)-3 Amant §.S-nowilqiasiu udrsrutuendlAlagniansoonsnha a, Tnuirmneigaiiourtalinitenrinn nade s.s- a amuuALAT aiinias uAMaNANsle ia ; nu Yoilandusaymaavidsnardunrandisia UnANIAAN uifupsaynoadtyindtumaaidelsinauunmiana Tar Feilaruaeidhuntiqndmsinésinowiinywnenslage nena Fawcinstianlurplans a) Suuuiladefiuny windy woven S! S()loleisatsnsurSusnynoa Aqndtunraandelvinmunftiauss nth RR Clitaueite 600 wh unswanmuslatotens 12 vn uonginii ()-duiaynoa debinathiusAquussinfauAn dinaio -einnioearne uavenariibiamsnalé Tenvniraiuscaseuualaestyn eniligitnatungiivewaeice iarmoennatHurdusuynoalihy avi Maines wolintumayantuawnitn 25 an/nn/a 9x shina wonnarontuuingtrwitusieemelvionyayy ueitvio Tila rnimilatngaitetudnnserh Vin itundanrainsmunatiign Aodhunaatiodasaymantuinvetosimanaaymayiihalset Wangan 4 Strumunrranthsienoonéusnynonssentusuragesovityiny meansihinminaartenwld wadiamvontarsmitmwanse sus yrontomuniisinnavietortuaneitelotametis 3 sos Ban yroa Turin iunnmoartinuinssadtuguinaalslasnaalsaity wihvuacenmilidetimnln aeaundt¥launtsliaa 25 ain/an sombniné TasliigaTulaisusnuacannsivie 15 sinvantiu wo ‘Vitremwrtumeien 19 xnynn/iu vActuntssiowtomh UailnausaasionTientumna 30 sa/nn Tauli 9 aserioaniind uet anitionwuniléoagunniin Touialunanandummlouo’aermsnaet ine wis wan th sifluinvalrenouFaagSunumlowsiamTusrmwhAn (60:50) shun penvinfulaunrnialigauuAletuodiuuanuduarlaweaqinos- ToissoStaungrauunihaovinereoulatadaubituanayrtianh Wiiqoimndfuandraituiaveanaounlacoraotoaeimenearanly nioviminnleucamasslaioimamwonoomnlaaliuunsubhu SuuuATosin’ Fodevorsinatlin shunrsusnsnsrisinotusela SuuuAlemodfivrsnnviqahultnniiesniomnnioteunsntves UNS Berane AIM NAT ALAIN TUT WlinladorinattoueTiiuduuuflawas woneindtsénaienAuanwilonieaanienarsaNruAihe owen 278 Aonvunnlaels ABlnsnlansiidana “Unialomlansit” deluilegiuinrsiann peiiuiitnondiantinsuunsaler uotnontrewns uasdnis judiousoy ()-loTaue%s09013 amino alcoho! Twingfunoser SuomymoauariienbhigrmbudinvosnialolanoTuninianits usodhslafimaf@nnrsouunarsuuidautondraeanean (4)-dussiy- mosWitaAisw 7 wneqnanintumreemomsainatlolstaics pnduenshafu n-snnnintudunougainwsosnainionssitila infavitnaunnAl fikumstudouses (QBumayneelutaggy ‘wes 52 («)-Busaryneadignnor dus tutes plan vsdinnewBuacfliignrtanneovlsdnaviaauds Modo Sinardxan=Hleunrainliniariesimas Sehitt base Ahunale < “une @-hydrony-2-one BeiBileswabiifin (Hlalumes uasuilvlotaefimtaunguin souiniBviieia no ‘@roswnnira9 epoxide ukrmruiun yuan ethylene diamine 2 ee Ino hidiounyunaiinas ()-5 ese even iets eesaeaamdpeena seh O-aine acon 8 AmntHtumanien (.)-Guoynoasociousniu soovnlgndvine GimnswMUaDS S4-epoybutt-one fuundntamasilatterion sluvioftindutautomoorhnvsuunerslolannsA ee VitauTirransininy (-tartaric acid Tusimmasininavinih ash 22UF (4)-2-aminobutanollc tanraie Autqna ucthihvanaatniunyt sumnuadanauias 7 Ruflessitiflolmuet 7 ampansndat ne dovhnnsaunevinawntgniiansnaninninsaelanslanr nm SBmaiainmesiznstsh amino alcohol AiVieraluilaunewint iasan t-aminobutan-2-01 inkuaucod via Darin _Tigermnazaiifioncummiiftazes ist (4)1-aminobutan-2-o1 thos atholoiimaiouneesinvaaausgnanviurosdumnmeatinaaigsiios arnenmmutgnives’ gfufifBuansTlountiAuarouettos ain Shugnashduatovauaile dpa eft pro nunZhguainsessWaouiO”: wicinuselomizp elt indolalainnslatvovefuosiynoaiindalinenauny Twili snexgnaitiluninreoqeumutinenunrnansndusnynaniith Faqhuielirmiiqunwniu Wak 431R, 1H-NMR, Powder x ‘ay. Thermoaravimotric F247) Microbial assay, Titration , Color ‘meric gravimetric (Analytical Profiles of Drug Substances. Vol 7, 1978, Now York: Academic Press, pp 231-249) Szpmnunraioahrarioshiinvienstiinaumnyveats Anns nieu (dermatitis) Guulautiamty (singing) Gury ounFramtus onniliouuidtniosinninaalilumantorinqiviosndunnmas uirsoruga mass caeornstaiiusuodrssowws Amaymnaiidinnetinis Asthiuituhsontiinnaanifinetos iminnviinneivanunraudiousesungusaymodtuan diay 970 kenzo saigo‘lolalanuosiisionnsmedammrmoundanesunsn ddufnowhdunnnoa eithilamamseerunrgmamadnanaens Sagfiudsfinrndaitgarindanrsinymuensinnio9076h Aiprinntuindeiiurocanigeuiin (USP) Wiiwranmgrun a wigninnlniaroar tusnynonichringbal nal tsiora nny senna lammushuhiton sniaiibilaradiweursrr Yaoi treBasrAocn Duar turernhy Walon sthsiseimrmnumuucatonesouBusymaaiinannn (137 vf tree base une + 7.7. diwfinnfa hydrochloride) Soviibines Aramesiauiaddaniaieeings uavidmendvadeihbmadanty suynan7 anita aaTn (es) Ta aAMAMaMA maZAATA Dunas (9-leluaeFlaunes uactalsiolstutdalasiqaumnluns Daseunumafhineediuevniuiloudsulngfving@uowundussynee sehusBAs dollunerastinneimoanetlainiinasarsiriimintu USP AslsbinapigniooviewofwtinnwinnmassynuboutweAy Guuuileunin, We lwnagamwnesin van wanenes uilileTauistviaiauian Ton¥38 Gas Chromatography 139 Cape AqalanasosnaVIqnayrslrianas(.)-Susiynna Hihinse! fiinarennFinaaes (-) Lote sie SLiflduangininanisonsalseanaahannlsos (-)-dussiynoaluinngs Vdivind uexiivfnnemsmyaat: amino butanol uogluingéy Asulyeiishbintaneisviowniviy Aivnrsanesleta sosrduny moans urininlimioaryysEnsdinnshMe TniaFwtumsivion —4e3sledalnariinnsA (Chiral HPLC) ge ary Zone Electrophoresis FanutilgmmlunsiasivtieseviniaTalawinSiovsanpa Bins roasnnieminedlelaainiane omino butanol AiuensAemllanae ust sina eh bivnuissfosiiugabuuesRowanrenunogumunraAinn Tairetmnlnaundstinraastngiuntsitueninestinninnen unsislanaywathsiivingfuvanorlssundamdaloeiaslewsnnin szogluureinmunuiody ahi $i Wodudy Tass uinstainives sanunafenrutein JhienanntinrsséaAitoaretinlSuatagen inengn usleuishiqnniesnsingguh Sone ynfinayionuuaparn uscdouraingaininnewmayram furewinauanigmaefuncqumsawn Foi msasz9n signs snstaqautBunutlersinfiaeAerhurindontuutnraninisn Fansantaso mundane: Fon cindavianrmnrenanauqncunirtooon iamnow onynuasontadueefondranmnnaigeurnnsesensussarog Tau lovesndsiomorniquumanergmsciagiy mmunanin si jaurmmnnaninioundaaypivedasenuntaundSeploserdusinmon Tou visiousliniuaenanssmmamuaunM noose m mutual javivaendunuynoalagnbionsonsndimiuda \onurtiuleeriTsowemnalansiiduneys shin unryrositan wetwaldufiiavinoauiiousasconnnalelaaias Tuhaqivsnseiusnymoaiuslounses wursrogtin tonersbr9bs Hassan ¥. Aboul-Enein and Irving W. Wainer, 1997. In: THe Impact of stereochemistry on drug dovolopment and use, Jahn Wiley & Son, USA pp, 295-201. ynauyndamunaunsrmadenn poustntaman’ aminnduavnewesund amalna) aver 90112 uw rehaabuwda Tangent ace Titi eel